NXTC - Rasio utang marang kapitalisasi buku NextCure, Inc.

The ratio of debt obligations to balance sheet equity demonstrates the credit load of NextCure, Inc. (NXTC), where the value 0.35 shows the current magnitude. The automation of tissue analysis via robotics accelerates scientific research, reducing personnel risks. NextCure, Inc. (NXTC) creates unique antibodies through the FIND platform to combat cancer, strictly adhering to environmental regulations for biohazardous waste disposal.

NXTC NextCure, Inc.: Rasio utang marang kapitalisasi buku ing interval 04.07.2022 - 27.10.2026

Ringkesan rincian data analitis NextCure Inc (NXTC)

- rega lan prakiraan konsensus rega:

Rega saham NextCure, Inc.|NXTC - Target konsensus

- data kapitalisasi pasar:

Nilai pasar NextCure Corporation|NXTC - Total Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham NextCure|NXTC - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku nextcure.com|NXTC - Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal NextCure, Inc.|NXTC - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas NextCure Corp|NXTC - Utang kumulatif perusahaan|Utang marang nilai buku NextCure Corporation

Analisis kabeh metrik perusahaan:NXTC, NextCure, Inc.

This ratio measures the proportion of debt relative to the company's equity on the balance sheet. Low values indicate financial stability, while an increase points to a rising debt load. By analyzing the debt-to-book capitalization trend, an investor assesses the risk of bankruptcy. For NextCure, Inc. (NXTC), this is critical, as R&D processes depend on liquidity. Stable leverage confirms the ability of patents to sustain the business until clinical trials are completed.

Pesaing NextCure, Inc.